Previous work suggested it significantly inhibits vascular endothelial growth factor expression in affected rat synovial joints[18] and regulates T cell subsets[19]; treatment of active RA with BZX had a good outcome, improving the patients’ morning stiffness, joint pain, joint swelling, and joint tenderness more rapidly than Methotrexate[20]. Here, VEGFA is linked to rheumatoid arthritis.